Form4insider filings, from the source

SEC Form 5 · accession 0001209191-17-009463

SPECTRUM PHARMACEUTICALS INC · SPPI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Rajesh C Shrotriya M.D.
Officer — Chairman & CEO · Director · 10% Owner
Period of report
Dec 31, 2016
Accepted (ET)
Feb 10, 2017 · 2:54 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000831547

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, $.001 Par ValueFeb 9, 2016G9,000$0.00D1,797,024D
Common Stock, $.001 Par ValueFeb 9, 2016G6,000$0.00D1,797,024D
Common Stock, $.001 Par ValueF3Dec 19, 2016G4,320$0.00D69,349IBy Shrotriya Family Foundation
Common Stock, $.001 Par ValueOct 3, 2016G10,613$0.00A1,797,024D
Common Stock, $.001 Par ValueF4Oct 3, 2016G10,613$0.00D0IBy Shrotriya Annuity Trust
Common Stock, $.001 Par Valueholding———498,894IBy CS Family Trust
Common Stock, $.001 Par Valueholding———87,018IBy Shrotriya Gift Trust
Common Stock, $.001 Par Valueholding———27,976IBy 401(k) plan
Common Stock, $.001 Par Valueholding———9,523IBy Spouse

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses